Cancer stem cells (CSC) can self-renew and differentiate to recapitulate the cellular heterogeneity of the original tumor [41], and Al-Hajj et al. have isolated CD44+, CD24−/low breast cancer initiating cells with CSC-like properties [42]. This evidence concerns the gene CD24 and breast carcinoma.